<DOC>
	<DOCNO>NCT00983021</DOCNO>
	<brief_summary>This trial conduct Europe . The aim clinical trial investigate safety , tolerability , level drug exposure effect NN9068 . The trial participant randomise 4 different treatment trial , receive trial product pre-defined order .</brief_summary>
	<brief_title>Safety Tolerability NN9068 Healthy Male Volunteers</brief_title>
	<detailed_description />
	<mesh_term>Insulin , Globin Zinc</mesh_term>
	<mesh_term>Insulin</mesh_term>
	<mesh_term>Insulin , Long-Acting</mesh_term>
	<mesh_term>Liraglutide</mesh_term>
	<criteria>Male subject , consider generally healthy , base assessment medical history , physical examination , clinical laboratory data , judge Investigator . Body mass index ( BMI ) 18.0 27.0 kg/m2 ( inclusive ) Body weight 60 kg 90 kg ( inclusive ) Subjects history presence cancer , diabetes , clinically significant cardiovascular , respiratory , metabolic , renal , hepatic , gastrointestinal , endocrinological , haematological , dermatological , venereal , neurological , psychiatric disease major disorder might impact current trial , judge Investigator</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>February 2017</verification_date>
</DOC>